Is FFP Overused? (EP Video)

The Year in Cardiothoracic and Vascular Anesthesia: Selected Highlights from 2012

The year 2012 has witnessed the emergence of new paradigms of care in our specialty with the emphasis on teamwork, safety, and quality. These processes will further improve perioperative outcome.

Diabetes Clinical Trials: Helped or Hindered by the Current Shift in Regulatory Requirements

The potential for some agents to increase the risk of cardiovascular events has led to substantial changes in regulatory requirements for new anti-diabetic therapies. These requirements, while key to ensuring the cardiovascular safety of new agents, fail to emphasize the need to show clinical benefits, such as less visual impairment, less need for dialysis, or fewer cardiovascular events and deaths.